Molina Healthcare (NYSE:MOH) Releases Quarterly Earnings Results, Misses Expectations By $2.13 EPS

Molina Healthcare (NYSE:MOH) posted its earnings results on Wednesday. The company reported $1.84 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.97 by ($2.13), Zacks reports. Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The firm had revenue of $11.48 billion for the quarter, compared to analysts’ expectations of $10.99 billion. During the same period in the previous year, the company earned $6.01 earnings per share. The company’s revenue was up 11.0% compared to the same quarter last year. Molina Healthcare updated its FY 2025 guidance to 14.000-14.000 EPS.

Molina Healthcare Trading Down 1.1%

Shares of Molina Healthcare stock opened at $194.58 on Thursday. The firm has a market capitalization of $10.55 billion, a PE ratio of 9.59 and a beta of 0.55. Molina Healthcare has a twelve month low of $151.95 and a twelve month high of $359.97. The firm’s 50-day moving average price is $184.26 and its 200 day moving average price is $241.71. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.77.

Insider Buying and Selling

In other Molina Healthcare news, Director Ronna Romney sold 700 shares of the firm’s stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total value of $107,618.00. Following the transaction, the director directly owned 17,131 shares of the company’s stock, valued at $2,633,719.94. This trade represents a 3.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO James Woys bought 10,000 shares of the firm’s stock in a transaction on Monday, August 4th. The stock was acquired at an average cost of $155.94 per share, for a total transaction of $1,559,400.00. Following the completion of the purchase, the chief operating officer directly owned 74,331 shares in the company, valued at approximately $11,591,176.14. This represents a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. MUFG Securities EMEA plc purchased a new position in Molina Healthcare in the 2nd quarter worth approximately $48,000. Smartleaf Asset Management LLC increased its holdings in shares of Molina Healthcare by 30.4% during the 2nd quarter. Smartleaf Asset Management LLC now owns 690 shares of the company’s stock worth $205,000 after buying an additional 161 shares during the last quarter. Baird Financial Group Inc. acquired a new stake in shares of Molina Healthcare during the 1st quarter worth approximately $210,000. State of Wyoming acquired a new stake in shares of Molina Healthcare during the 2nd quarter worth approximately $235,000. Finally, NewEdge Advisors LLC increased its holdings in shares of Molina Healthcare by 33.4% during the 1st quarter. NewEdge Advisors LLC now owns 1,106 shares of the company’s stock worth $364,000 after buying an additional 277 shares during the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

MOH has been the topic of several recent analyst reports. Wells Fargo & Company increased their target price on shares of Molina Healthcare from $198.00 to $231.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Cantor Fitzgerald reissued a “neutral” rating and set a $210.00 target price on shares of Molina Healthcare in a research note on Tuesday, August 26th. Barclays lowered their target price on shares of Molina Healthcare from $186.00 to $185.00 and set an “equal weight” rating on the stock in a research note on Thursday, September 4th. Morgan Stanley increased their target price on shares of Molina Healthcare from $163.00 to $204.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 14th. Finally, UBS Group lowered their target price on shares of Molina Healthcare from $260.00 to $180.00 and set a “neutral” rating on the stock in a research note on Friday, July 25th. Three equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $222.15.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.